Lendalizumab (Anti-Complement C5)
Product Specifications
CAS Number
2210314-30-8
Synonyms
ALXN1007, Olendalizumab
SKU
C00605-1mg
Target
Complement System
Applications
Immunology & Inflammation
Additionnal Information
Lendalizumab (Anti-Complement C5) is a proprietary antibody that targets the complement protein C5a with potential immunomodulating and anti-inflammatory activities. MW : 146.02 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1146346-01 0.02 mg (E-Coli)
Recombinant Shewanella baltica Elongation factor Ts (tsf)
Ask
View Details 
MBS1146346-02 0.02 mg (Yeast)
Recombinant Shewanella baltica Elongation factor Ts (tsf)
Ask
View Details MBS1146346-03 0.1 mg (E-Coli)
Recombinant Shewanella baltica Elongation factor Ts (tsf)
Ask
View Details 
MBS1146346-04 0.1 mg (Yeast)
Recombinant Shewanella baltica Elongation factor Ts (tsf)
Ask
View Details MBS1146346-05 0.02 mg (Baculovirus)
Recombinant Shewanella baltica Elongation factor Ts (tsf)
Ask
View Details MBS1146346-06 0.02 mg (Mammalian-Cell)
Recombinant Shewanella baltica Elongation factor Ts (tsf)
Ask
View Details